inmedpharma.com (INM) Company Sales

InMed Pharmaceuticals (INM) possesses an impeccable scientific reputation in the field of medical biosynthesis. The company is developing B2B production of rare cannabinoids to treat glaucoma, aiming to capture a niche in the pharmaceutical narcotics sector. Corporate sales dynamics visualize these processes, where 0.00 captures the current value of the indicator. However, geopolitical tensions and sanctions are limiting drug exports, thereby reducing available target markets.

INM inmedpharma.com: Revenue and Sales Volume in the range 07/04/2022 - 11/09/2026

Analytical breakdowns for InMed Pharmaceuticals

- current price and projected stock value:

Share Price InMed|INM - Price Target Chart

- market capitalization details:

Market Valuation InMed Pharmaceuticals Inc.|INM - Enterprise Value

- balance sheet equity data:

Net Asset Value per Share InMed Pharmaceuticals|INM - Book Capitalization|Capitalization to Book Value Ratio inmedpharma.com|INM - Cumulative Company Assets

- debt and solvency information:

All Debt to Shareholders' Equity Ratio InMed Pharmaceuticals|INM - Long-Term Debt to Equity|Current Liabilities to Equity InMed Pharmaceuticals Inc|INM - Company Aggregate Debts|Debt to Net Assets Ratio InMed Pharmaceuticals Inc.|INM - Company Long-Term Debts|Company Short-Term Debts InMed Pharmaceuticals|Intermediate Coverage Ratio inmedpharma.com

- business earnings and investment ratios data:

INM - Company Net Income|Future Profit InMed Pharmaceuticals|INM - P/E Multiple|Forward P/E Multiple inmedpharma.com|INM - PEG Multiple|Enterprise Value to EBITDA Ratio InMed Pharmaceuticals Inc.|INM - Operating profit EBITDA|Net earnings per one share for the last twelve months InMed Pharmaceuticals|INM - Net earnings per share for the last 12 months|Quarterly EPS earnings growth inmedpharma.com|INM - Net earnings per share growth this year|Projected earnings per share increase next year InMed Pharmaceuticals

- company sales and revenue statistics:

INM - Revenue and Sales Volume|Company Future Sales InMed|INM - P/S Multiple|Forward Price-to-Revenue Multiple InMed Pharmaceuticals Inc.

Summary company analysis:InMed - INM

This indicator tracks the daily net revenue of InMed Pharmaceuticals (INM), enabling a real-time assessment of actual market demand and the resilience of the issuer's commercial model. Analyzing the company's sales metrics helps identify liquidity shortages, which, during the prolonged development of ophthalmology drugs, could lead to equity dilution to fund Phase II clinical trials.

Key competitors